M.D.C. Holdings Analyst Ratings
M.D.C. Holdings Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/22/2022 | -10.4% | JP Morgan | $27 → $28 | Downgrades | Neutral → Underweight |
| 11/03/2022 | -13.6% | JP Morgan | $31.5 → $27 | Maintains | Neutral |
| 10/21/2022 | — | Raymond James | Downgrades | Strong Buy → Market Perform | |
| 08/01/2022 | 40.8% | Raymond James | $77 → $44 | Maintains | Strong Buy |
| 07/12/2022 | 21.6% | JP Morgan | $40.5 → $38 | Maintains | Neutral |
| 06/17/2022 | -13.6% | Wells Fargo | → $27 | Downgrades | Equal-Weight → Underweight |
| 04/13/2022 | 24.8% | JP Morgan | $49 → $39 | Maintains | Neutral |
| 03/10/2022 | 56.8% | JP Morgan | $66 → $49 | Maintains | Neutral |
| 11/08/2021 | 146.4% | Raymond James | $79 → $77 | Maintains | Strong Buy |
| 10/14/2021 | 111.2% | JP Morgan | → $66 | Downgrades | Overweight → Neutral |
| 08/19/2021 | 152.8% | Raymond James | $80 → $79 | Maintains | Strong Buy |
| 04/16/2021 | 108% | Wells Fargo | → $65 | Initiates Coverage On | → Equal-Weight |
| 03/16/2021 | — | Wolfe Research | Initiates Coverage On | → Peer Perform | |
| 03/12/2021 | 101.6% | B of A Securities | → $63 | Downgrades | Neutral → Underperform |
| 01/25/2021 | 127.2% | Raymond James | $61 → $71 | Maintains | Strong Buy |
| 01/05/2021 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 10/30/2020 | 47.2% | Wells Fargo | → $46 | Upgrades | Underweight → Equal-Weight |
| 10/08/2020 | 114.4% | JP Morgan | → $67 | Upgrades | Neutral → Overweight |
| 09/15/2020 | 82.4% | B of A Securities | → $57 | Upgrades | Neutral → Buy |
| 07/29/2020 | 60% | JP Morgan | $38.5 → $50 | Maintains | Neutral |
| 07/29/2020 | 95.2% | Evercore ISI Group | → $61 | Upgrades | In-Line → Outperform |
| 06/05/2020 | 18.4% | Evercore ISI Group | → $37 | Downgrades | Outperform → In-Line |
| 04/09/2020 | 12% | Raymond James | $52 → $35 | Reiterates | → Strong Buy |
| 03/18/2020 | -29.6% | JP Morgan | $46.5 → $22 | Maintains | Neutral |
| 01/31/2020 | 34.4% | Wells Fargo | $39 → $42 | Downgrades | Equal-Weight → Underweight |
| 09/13/2019 | 31.2% | Wedbush | $35 → $41 | Maintains | Neutral |
| 09/13/2019 | 56.8% | Raymond James | $42 → $49 | Upgrades | Outperform → Strong Buy |
| 08/01/2019 | 12% | Wedbush | $30 → $35 | Reiterates | → Neutral |
| 11/12/2018 | 2.4% | Wedbush | $31 → $32 | Maintains | Neutral |
| 11/02/2018 | -0.8% | Wedbush | $34 → $31 | Maintains | Neutral |
| 10/25/2018 | -0.8% | Evercore ISI Group | $33 → $31 | Upgrades | In-Line → Outperform |
| 09/21/2018 | 2.4% | JP Morgan | $38 → $32 | Downgrades | Neutral → Underweight |
| 08/02/2018 | 8.8% | Wedbush | $33 → $34 | Maintains | Neutral |
| 08/02/2018 | — | B of A Securities | Upgrades | Underperform → Buy | |
| 07/13/2018 | — | JP Morgan | Upgrades | Underweight → Neutral | |
| 05/08/2018 | 24.8% | Raymond James | $35 → $39 | Maintains | Outperform |
| 05/04/2018 | — | Zelman | Upgrades | Hold → Buy | |
| 03/20/2018 | -4% | Wedbush | → $30 | Initiates Coverage On | → Neutral |
| 03/13/2018 | — | UBS | Upgrades | Sell → Buy | |
| 02/13/2018 | — | Raymond James | Upgrades | Market Perform → Outperform | |
| 02/02/2018 | 8.8% | B of A Securities | $31 → $34 | Maintains | Underperform |
| 01/03/2018 | — | Evercore ISI Group | Upgrades | Underperform → In-Line |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 11/22/2022 | -10.4% | 摩根大通 | $27 → $28 | 评级下调 | 中性→减持 |
| 11/03/2022 | -13.6% | 摩根大通 | $31.5 → $27 | 维护 | 中性 |
| 10/21/2022 | — | 雷蒙德·詹姆斯 | 评级下调 | 强劲的购买→市场表现 | |
| 08/01/2022 | 40.8% | 雷蒙德·詹姆斯 | $77 → $44 | 维护 | 强势购买 |
| 07/12/2022 | 21.6% | 摩根大通 | $40.5 → $38 | 维护 | 中性 |
| 06/17/2022 | -13.6% | 富国银行 | → $27 | 评级下调 | 等重→减码 |
| 04/13/2022 | 24.8% | 摩根大通 | $49 → $39 | 维护 | 中性 |
| 03/10/2022 | 56.8% | 摩根大通 | $66 → $49 | 维护 | 中性 |
| 11/08/2021 | 146.4% | 雷蒙德·詹姆斯 | $79 → $77 | 维护 | 强势购买 |
| 10/14/2021 | 111.2% | 摩根大通 | → $66 | 评级下调 | 超重→中性 |
| 08/19/2021 | 152.8% | 雷蒙德·詹姆斯 | $80 → $79 | 维护 | 强势购买 |
| 04/16/2021 | 108% | 富国银行 | → $65 | 开始承保 | →等重 |
| 03/16/2021 | — | 沃尔夫研究 | 开始承保 | →对等性能 | |
| 03/12/2021 | 101.6% | B of A证券 | → $63 | 评级下调 | 中性→表现不佳 |
| 01/25/2021 | 127.2% | 雷蒙德·詹姆斯 | $61 → $71 | 维护 | 强势购买 |
| 01/05/2021 | — | B of A证券 | 评级下调 | 购买→中性 | |
| 10/30/2020 | 47.2% | 富国银行 | → $46 | 升级 | 重量不足的→等重 |
| 10/08/2020 | 114.4% | 摩根大通 | → $67 | 升级 | 中性→超重 |
| 09/15/2020 | 82.4% | B of A证券 | → $57 | 升级 | 中性→购买 |
| 07/29/2020 | 60% | 摩根大通 | $38.5 → $50 | 维护 | 中性 |
| 07/29/2020 | 95.2% | Evercore ISI集团 | → $61 | 升级 | 线内→表现优异 |
| 06/05/2020 | 18.4% | Evercore ISI集团 | → $37 | 评级下调 | 胜过→同线 |
| 04/09/2020 | 12% | 雷蒙德·詹姆斯 | $52 → $35 | 重申 | →强势购买 |
| 03/18/2020 | -29.6% | 摩根大通 | $46.5 → $22 | 维护 | 中性 |
| 01/31/2020 | 34.4% | 富国银行 | $39 → $42 | 评级下调 | 等重→减码 |
| 09/13/2019 | 31.2% | 韦德布什 | $35 → $41 | 维护 | 中性 |
| 09/13/2019 | 56.8% | 雷蒙德·詹姆斯 | $42 → $49 | 升级 | 跑赢→强势买入 |
| 08/01/2019 | 12% | 韦德布什 | $30 → $35 | 重申 | →中性 |
| 11/12/2018 | 2.4% | 韦德布什 | $31 → $32 | 维护 | 中性 |
| 11/02/2018 | -0.8% | 韦德布什 | $34 → $31 | 维护 | 中性 |
| 10/25/2018 | -0.8% | Evercore ISI集团 | $33 → $31 | 升级 | 线内→表现优异 |
| 09/21/2018 | 2.4% | 摩根大通 | $38 → $32 | 评级下调 | 中性→减持 |
| 08/02/2018 | 8.8% | 韦德布什 | $33 → $34 | 维护 | 中性 |
| 08/02/2018 | — | B of A证券 | 升级 | 表现不佳的→收购 | |
| 07/13/2018 | — | 摩根大通 | 升级 | 减重→中性 | |
| 05/08/2018 | 24.8% | 雷蒙德·詹姆斯 | $35 → $39 | 维护 | 跑赢大盘 |
| 05/04/2018 | — | 泽尔曼 | 升级 | 持有→购买 | |
| 03/20/2018 | -4% | 韦德布什 | → $30 | 开始承保 | →中性 |
| 03/13/2018 | — | 瑞银集团 | 升级 | 卖出→买入 | |
| 02/13/2018 | — | 雷蒙德·詹姆斯 | 升级 | 市场表现优于→ | |
| 02/02/2018 | 8.8% | B of A证券 | $31 → $34 | 维护 | 表现不佳 |
| 01/03/2018 | — | Evercore ISI集团 | 升级 | 表现不佳的直插式→ |
What is the target price for M.D.C. Holdings (MDC)?
M.D.C.Holdings(MDC)的目标价是多少？
The latest price target for M.D.C. Holdings (NYSE: MDC) was reported by JP Morgan on November 22, 2022. The analyst firm set a price target for $28.00 expecting MDC to fall to within 12 months (a possible -10.40% downside). 8 analyst firms have reported ratings in the last year.
摩根大通于2022年11月22日报道了M.D.C.Holdings(纽约证券交易所代码：MDC)的最新目标价。这家分析公司将目标价定为28.00美元，预计MDC将在12个月内下跌(可能下跌10.40%)。去年有8家分析公司公布了评级。
What is the most recent analyst rating for M.D.C. Holdings (MDC)?
分析师对M.D.C.Holdings(MDC)的最新评级是多少？
The latest analyst rating for M.D.C. Holdings (NYSE: MDC) was provided by JP Morgan, and M.D.C. Holdings downgraded their underweight rating.
摩根大通对M.D.C.Holdings(纽约证券交易所代码：MDC)的最新分析师评级是由摩根大通提供的，M.D.C.Holdings下调了其减持评级。
When is the next analyst rating going to be posted or updated for M.D.C. Holdings (MDC)?
M.D.C.Holdings(MDC)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of M.D.C. Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for M.D.C. Holdings was filed on November 22, 2022 so you should expect the next rating to be made available sometime around November 22, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公开的财务报表，与M.D.C.Holdings的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。M.D.C.Holdings的上一次评级是在2022年11月22日提交的，所以你应该预计下一次评级将在2023年11月22日左右的某个时候公布。
Is the Analyst Rating M.D.C. Holdings (MDC) correct?
分析师对M.D.C.Holdings(MDC)的评级正确吗？
While ratings are subjective and will change, the latest M.D.C. Holdings (MDC) rating was a downgraded with a price target of $27.00 to $28.00. The current price M.D.C. Holdings (MDC) is trading at is $31.25, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但M.D.C.Holdings(MDC)的最新评级被下调，目标价为27.00美元至28.00美元。M.D.C.Holdings(MDC)目前的股价为31.25美元，超出了分析师的预测区间。